104 related articles for article (PubMed ID: 8141820)
1. Sex difference in pharmacokinetics of the novel sulfonylurea antidiabetic glimepiride in rats.
Yamazaki H; Tabata S
Arzneimittelforschung; 1993 Dec; 43(12):1317-21. PubMed ID: 8141820
[TBL] [Abstract][Full Text] [Related]
2. Glimepiride pharmacokinetics in obese versus non-obese diabetic patients.
Shukla UA; Chi EM; Lehr KH
Ann Pharmacother; 2004 Jan; 38(1):30-5. PubMed ID: 14742789
[TBL] [Abstract][Full Text] [Related]
3. [Preparation and evaluation in vivo and in vitro of glimepiride gel-matrix controlled-release patch].
Zhang Y; Xu DH; Ma Z; Chen Y; Zhao JJ; Xu SB
Yao Xue Xue Bao; 2004 Aug; 39(8):640-4. PubMed ID: 15563069
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and metabolism of 14C-glipentide, a new antidiabetic, after oral and intravenous administration.
Chanal JL; Calmette MT; Khiat M; Rimbau V; Vera A
Arzneimittelforschung; 1977; 27(4):852-6. PubMed ID: 577463
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH
Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 1st communication: absorption, concentrations in plasma, metabolism, and excretion after single administration to rats and dogs.
Boberg M; Ahr HJ; Beckermann B; Bühner K; Siefert HM; Steinke W; Wünsche C; Hirayama M
Arzneimittelforschung; 1997 Aug; 47(8):928-38. PubMed ID: 9296279
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of the gastrokinetic agent mosapride citrate after intravenous and oral administrations in rats.
Sakashita M; Mizuki Y; Hashizume T; Yamaguchi T; Miyazaki H; Sekine Y
Arzneimittelforschung; 1993 Aug; 43(8):859-63. PubMed ID: 8216443
[TBL] [Abstract][Full Text] [Related]
8. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of troglitazone, an antidiabetic agent: prediction of in vivo stereoselective sulfation and glucuronidation from in vitro data.
Izumi T; Hosiyama K; Enomoto S; Sasahara K; Sugiyama Y
J Pharmacol Exp Ther; 1997 Mar; 280(3):1392-400. PubMed ID: 9067328
[TBL] [Abstract][Full Text] [Related]
10. Effects of fluconazole and fluvoxamine on the pharmacokinetics and pharmacodynamics of glimepiride.
Niemi M; Backman JT; Neuvonen M; Laitila J; Neuvonen PJ; Kivistö KT
Clin Pharmacol Ther; 2001 Apr; 69(4):194-200. PubMed ID: 11309547
[TBL] [Abstract][Full Text] [Related]
11. Influence of cholestyramine on the pharmacokinetics of rosiglitazone and its metabolite, desmethylrosiglitazone, after oral and intravenous dosing of rosiglitazone: impact on oral bioavailability, absorption, and metabolic disposition in rats.
Muzeeb S; Venkatesh P; Mullangi R; Srinivas NR
Xenobiotica; 2006 Sep; 36(9):838-56. PubMed ID: 16971347
[TBL] [Abstract][Full Text] [Related]
12. Replicate study design in bioequivalency assessment, pros and cons: bioavailabilities of the antidiabetic drugs pioglitazone and glimepiride present in a fixed-dose combination formulation.
Karim A; Zhao Z; Slater M; Bradford D; Schuster J; Laurent A
J Clin Pharmacol; 2007 Jul; 47(7):806-16. PubMed ID: 17463215
[TBL] [Abstract][Full Text] [Related]
13. Effects of liver fibrosis on verapamil pharmacokinetics in rats.
Chen M; Xu D; Hu XL; Wang H
Clin Exp Pharmacol Physiol; 2008 Mar; 35(3):287-94. PubMed ID: 17973928
[TBL] [Abstract][Full Text] [Related]
14. Disposition and metabolism of the new oral antidiabetic drug troglitazone in rats, mice and dogs.
Kawai K; Kawasaki-Tokui Y; Odaka T; Tsuruta F; Kazui M; Iwabuchi H; Nakamura T; Kinoshita T; Ikeda T; Yoshioka T; Komai T; Nakamura K
Arzneimittelforschung; 1997 Apr; 47(4):356-68. PubMed ID: 9150855
[TBL] [Abstract][Full Text] [Related]
15. Disposition of the dipeptidyl peptidase 4 inhibitor sitagliptin in rats and dogs.
Beconi MG; Reed JR; Teffera Y; Xia YQ; Kochansky CJ; Liu DQ; Xu S; Elmore CS; Ciccotto S; Hora DF; Stearns RA; Vincent SH
Drug Metab Dispos; 2007 Apr; 35(4):525-32. PubMed ID: 17220241
[TBL] [Abstract][Full Text] [Related]
16. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
17. Comparison of pharmacokinetics of M1, M2, M3, and M4 after intravenous administration of DA-125 or ME2303 to mice and rats. New adriamycin analogues containing fluorine.
Yoon EJ; Lee WI; Shim HJ; Lee SD; Kim WB; Yang J; Lee MG
Biopharm Drug Dispos; 1996 Jul; 17(5):373-420. PubMed ID: 8830976
[TBL] [Abstract][Full Text] [Related]
18. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
[TBL] [Abstract][Full Text] [Related]
19. Determination of the absolute bioavailability of glimepiride (HOE 490), a new sulphonylurea.
Badian M; Korn A; Lehr KH; Malerczyk V; Waldhäusl W
Int J Clin Pharmacol Ther Toxicol; 1992 Nov; 30(11):481-2. PubMed ID: 1490793
[No Abstract] [Full Text] [Related]
20. Hepatic microsomal enzyme induction, beta-oxidation, and cell proliferation following administration of clofibrate, gemfibrozil, or bezafibrate in the CD rat.
Amacher DE; Beck R; Schomaker SJ; Kenny CV
Toxicol Appl Pharmacol; 1997 Jan; 142(1):143-50. PubMed ID: 9007043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
